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Abstract
Accelerated cholesterol and lipid metabolism are the hallmarks of cancer and contribute to
malignant transformation due to the obligatory requirement for cholesterol for the function of
eukaryotic membranes. To build new membranes and maintain active signaling, cancer cells
depend on high intensity of endogenous cholesterol biosynthesis and uptake of lipid particles.
This metabolic dependency of cancer cells on cholesterol and other lipids is tightly regulated by
the cholesterol  homeostasis  network,  including (i)  sterol  response element-binding proteins
(SREBP),  master transcriptional  regulators of  cholesterol  and fatty acid pathway genes; (ii)
nuclear sterol receptors (liver X receptors, LXR), which coordinate growth with the availability of
cholesterol; and (iii) lipid particle receptors, such as low-density lipid particle (LDL) receptor,
providing  exogenous  sterol  and  lipids  to  cancer  cells.  In  addition,  activity  of  oncogenic
receptors, such as MUC1 or EGFR, accelerates sterol uptake and biosynthesis. Therefore, a
general strategy of reducing the cholesterol pool in cancer cells is challenged by the highly
efficient  feedback  loops  compensating  for  a  blockade at  a  single  point  in  the  cholesterol
homeostatic network. Besides the well-established structural role of cholesterol in membranes,
recent  studies  have  uncovered  potent  biologic  activities  of  certain  cholesterol  metabolic
precursors and its oxidized derivatives, oxysterols. The former, meiosis-activating sterols, exert
effects on trafficking and signaling of oncogenic EGF receptor (EGFR). Cholesterol epoxides, the
highly  active  products  of  cholesterol  oxidation,  are  being  neutralized  by  the  distal  sterol
pathway  enzymes,  emopamyl-binding  protein  (EBP)  and  dehydrocholesterol-7  reductase
(DHCR7). These recently discovered "moonlighting" activities of the cholesterol pathway genes
and  metabolites  expand  our  understanding  of  the  uniquely  conserved  roles  these  sterol
molecules play in the regulation of cellular proliferation and in cancer. Clin Cancer Res; 20(1);
28-34. © 2013 AACR.
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